Patient compliance data can be highly effective in phase 2 post hoc analyses leading up to the go/no go decision regarding a move to phase 3. Once the phase 2 objectives of assessing safety, tolerability and effectiveness have been met, the question is whether or not to proceed to phase 3 with its considerable resource requirements.
NFC Forum Certified
IMC, the global leader in Smart Medication Adherence Solutions, is proud to announce that our Electronic Content Monitoring NFC Tag is the world's only Medication Adherence Device certified and listed by NFC Forum.
Our Electronic Content Monitors (ECMs) provide valuable and objective insights into medication adherence; we provide NFC Forum-certified devices, HIPAA cloud platform, apps and helpdesk services.
Our connected adherence devices are designed with the patient in mind. Our innovative medication technologies are available for blister packs, pill bottles, syringes and custom formats.
Did you know?
Utilizing NFC-connected smart adherence packaging optimizes your clinical decisions by improving data accuracy.